Hofbauer, et al. found that inhibition of Tiam1-Rac1 signaling can antagonize the chemical resistance of chronic lymphocytic leukemia (CLL) cells to fludarabine (147). This evidence concerns the gene RAC1 and B-cell chronic lymphocytic leukemia.